Table 2 Characteristics of AE reports associated with netarsudil
Characteristics | Case number (n) | Case proportion (%) |
|---|---|---|
Gender | Â | Â |
 Female | 448 | 34.59 |
 Male | 304 | 23.47 |
 Unknown | 543 | 41.93 |
Age | Â | Â |
 < 18 | 19 | 1.47 |
 18–64 | 106 | 8.19 |
 65–98 | 241 | 18.61 |
 Unknown | 929 | 71.74 |
Serious Outcome | Â | Â |
 Death | 31 | 2.39 |
 Disability | 7 | 0.54 |
 Hospitalization | 6 | 0.46 |
 Life-threatening | 1 | 0.08 |
 Other serious outcomes | 101 | 7.80 |
Reporter country | Â | Â |
 United States of America | 1233 | 95.21 |
 Germany | 7 | 0.54 |
 India | 4 | 0.31 |
 Canada | 2 | 0.15 |
 Argentina | 1 | 0.08 |
 Denmark | 1 | 0.08 |
 Finland | 1 | 0.08 |
 Italy | 1 | 0.08 |
 Spain | 1 | 0.08 |
 Sweden | 1 | 0.08 |
 Country not specified | 43 | 3.32 |